A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene

Journal of Experimental Medicine

Volumn 183, Issue 3, 1996, Pages 1173-1183

  Guilloux, Yannik ^a   Lucas, Sophie ^a   Brichard, Vincent G ^a   Van Pel, Aline ^a   Viret, Christophe ^b   De Plaen, Etienne ^a   Brasseur, Francis ^a   Lethé, Bernard ^a   Jotereau, Francine ^b   Boon, Thierry ^a,c  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITÉ DE NANTES   (France)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLGLUCOSAMINYLTRANSFERASE; TUMOR ANTIGEN;

ARTICLE; CANCER IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRON; MELANOMA; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; TATA BOX;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; BASE SEQUENCE; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; DNA PRIMERS; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION; GENE LIBRARY; HLA-A2 ANTIGEN; HUMANS; INTRONS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MELANOMA; MOLECULAR SEQUENCE DATA; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASMS; POLYMERASE CHAIN REACTION; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; RESTRICTION MAPPING; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 15844363121     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.3.1173     Document Type: Article

References (43)

1. Boon, T., J.-C. Cerottini, B. Van den Eynde, P. van der Bruggen, and A. Van Pel. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:337-365.
2. Mukherji, B., and T.J. MacAlister. 1983. Clonal analysis of cytotoxic T cell response against human melanoma. J. Exp. Med. 158:240-245.
3. Knuth, A., B. Dnowski, H.F. Oettgen, and L. Old. 1984. T-cell mediated cytotoxiciry against autologous malignant melanoma: analysis with interleukin-2-dependent T-cell cultures. Proc. Natl. Acad. Sci. USA. 81:3511-3515.
4. Itoh, K., A.B. Tilden, and C.M. Balch. 1986. Interleukin-2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas. Cancer Res. 46:3011-3017.
5. Hérin, M., C. Lemoine, P. Weynants, F. Vessière, A. Van Pel, A. Knuth, R. Devos, and T. Boon. 1987. Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int. J. Cancer. 39:390-396.
6. Pandolfino, M.-C., C. Viret, N. Gervois, Y. Guilloux, F. Davodeau, E. Diez, and F. Jotereau. 1992. Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma-infiltrating lymphocytes. Eur. J. Immunol. 22:1795-1802.
7. van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash. DC). 254:1643-1647.
8. Gaugler, G., B. Van den Eynde, P. van der Bruggen, P. Romero, J.J. Gaforio, E. De Plaen, B. Lethé, F. Brasseur, and T. Boon. 1994. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179:921-930.
9. Boël, P., C. Wildmann, M.-L. Sensi, R. Brasseur, J.-C. Renauld, P. Coulie, T. Boon, and P van der Bruggen. 1995. BAGE, a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity. 2: 167-175.
10. Van den Eynde, B., O. Peeters, O. De Backer, B. Gaugler, S. Lucas, and T. Boon. 1995. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182:689-698.
11. Brichard, V., A. Van Pel, T. Wölfel, C. Wölfel, E. De Plaen, B. Lethé, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489-495.
12. Robbins, P.F., M. El-Gamil, Y. Kawakami, and S.A. Rosenberg. 1994. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res 54:3124-3126.
13. Topalian, S.L., L. Rivoltini, M. Mancini, N.R. Markus, P.F. Robbins, Y. Kawakami, and S.A. Rosenberg. 1994. Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc Natl. Acad. Sci. USA. 91:9461-9465.
14. Wölfel, T., A. Van Pel, V. Brichard, J. Schneider, B. Seliger, K.-H. Meyer zum Büschenfelde, and T. Boon. 1994 Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol. 24: 759-764.
15. Coulie, P G., V. Brichard, A. Van Pel, T. Wölfel, J. Schneider, C. Traversari, S. Mattei, E. De Plaen, C. Lurquin, J.-P. Szikora, J.-C. Renauld, and T. Boon. 1994. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp. Med. 180:35-42.
16. Kawakami, Y., S. Eliyahu, C.H. Delgado, P.F. Robbins, L. Rivoltini, S.L. Topalian, T. Miki, and S.A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA. 91:3515-3519.
17. Bakker, A.B.H., M.W.J. Schreurs, A.J. de Boer, Y. Kawakami, S.A. Rosenberg, G.J. Adema, and C.G. Figdor. 1994. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179:1005-1009.
18. Cox, A.L., J. Skipper, Y. Chen, R.A. Henderson, T.L. Darrow, J. Shabanowitz, V.H. Engelhard, D.F. Hunt, and C.L. Slingluff, Jr. 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science (Wash. DC). 264:716-719.
19. Wang, R.-F., P.F. Robbins, Y. Kawakami, X.-Q. Kang, and S.A. Rosenberg. 1995. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J. Exp. Med. 181:799-804.
20. Van den Eynde, B., P. Hainaut, M. Hérin, A. Knuth, C. Lemoine, P. Weynants, P. van der Bruggen, R. Fauchet, and T. Boon. 1989. Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int. J. Cancer. 44: 634-640.
21. Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular cloning. A Laboratory Manual. N. Ford, C. Nolan, and M. Ferguson, editors. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
22. Seed, B., and A. Aruffo. 1987. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immuno-selection procedure. Proc. Natl. Acad. Sci. USA. 84:3365-3369.
23. Wolfel, T., M. Hauer, E. Klehmann, V. Brichard, B. Ackermann, A. Knuth, T. Boon, and K.-H. Meyer zum Büschenfelde. 1993. Analysis of antigens recognized on human melanoma cells by A2-restricted cytolytic T lymphocytes (CTL). Int. J. Cancer. 55:237-244.
24. Traversan, C., P. van der Bruggen, B. Van den Eynde, P. Hainaut, C. Lemoine, N. Ohta, L. Old, and T. Boon. 1992. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics. 35:145-152.
25. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic ractor/tumor necrosis factor from human monocytes. J. Immunol Methods. 95:99-105.
26. Hansen, M.B., S.E. Nielsen, and K. Berg. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods. 119:203-210.
27. Frohman, M.A., M.K. Dush, and G.R. Martin. 1988. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc. Natl Acad. Sci. USA. 85:8998-9002.
28. Atherton, E., C.J. Logan, and R.C. Sheppard. 1981. Peptide synthesis. Part 2. Procedures for solid phase synthesis using Nα-fluorenylmethysoxycarbamylamino-acid on polymide supports. Synthesis of substance P and of acyl carrier protein 65-74 decapeptide. J. Chem. Soc Lond. Perkin Trans. 1:538.
29. Boon, T., J. Van Snick, A. Van Pel, C. Uyttenhove, and M. Marchand. 1980. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T Lymphocyte-mediated cytolysis. J. Exp. Med. 152:1184-1193.
30. Davis, L.G., M.D. Dibner, and J.F. Battey. 1986. Basic Methods in Molecular Biology. Elsevier, NY. 130-135.
31. Viret, C., F. Davodeau, Y. Guilloux, J.-D. Bignon, G. Semana, R. Breathnach, and F. Jotereau. 1993. Recognition of shared melanoma antigen by HLA-A2-restricted cytolytic T cell clones derived from human tumor-infiltrating lymphocytes. Eur. J. Immunol. 23:141-146.
32. +. Biochem. Biophys. Res. Commun. 198: 318-327.
33. Ruppert, J., H.M. Grey, A. Sette, R.T. Kubo, J. Sidney, and E. Celis. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell. 74:929-937.
34. Salter, R.D., D.N. Howell, and P. Cresswell. 1985. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics. 21:235-246.
35. Cerundolo, V., J. Alexander, K. Anderson, C. Lamb, P. Cresswell, A. McMichael, F. Gotch, and A. Townsend. 1990. Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature (Lond.). 345:449-452.
36. Cummings, R.D., I.S. Trowbridge, and S. Kornfeld. 1982. Mouse lymphoma cell line resistant to the leukoagglurinating lectin from Phaseolus vulargis is deficient in UDP-Glc NAc: α-D-mannoside β1, 6 N-acetylglucosaminyltransferase. J. Biol. Chem. 257:13421-13427.
37. Santer, U.V., F. Gilbert, and M.C. Glick. 1984. Change in glycosylation of membrane glycoproteins after transfection of NIH 3T3 with human tumor DNA. Cancer Res. 44:3730-3735.
38. Yamashita, K., Y. Tachibana, T. Ohkura, and A. Kobata. 1985. Enzymatic basis for the structural changes of asparagine-linked sugar chains of membrane glycoproteins of baby hamster kidney cells induced by polyoma transformation. J. Biol. Chem. 260:3963-3969.
39. Pierce, M., and J. Arango. 1986. Rous sarcoma virus-transformed baby hamster kidney cells express higher levels of asparagine-linked tri- and tetraantennary glycopeptides containing [GlcNAc-β(1,6)Man-α(1,6)Man] and poly-N-acetyllactosamine sequences than baby hamster kidney cells. J. Biol. Chem. 261:10772-10777.
40. Dennis, J.W., K. Kosh, D.-M. Bryce, and M.L. Breitman. 1989. Oncogenes conferring metastatic potential induce increased branching of Asn-linked oligosaccharides in rat2 fibroblasts. Oncogene. 4:853-860.
41. Easton, E.W., J.G.M. Bolscher, and D.H. van den Eijnden. 1991. Enzymatic amplification involving glycosyltransferases forms the basis for the increased size of Asparagine-linked glycans at the surface of NIH 3T3 cells expressing the N-ras proto-oncogene. J. Biol. Chem. 266:21674-21680.
42. Dennis, J.W., S. Laferté, C. Waghorne, M.L. Breitman, and R.S. Kerbel. 1987. β1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science (Wash. DC). 236:582-585.
43. Saitoh, O., W.-C. Wang, R. Lotan, and M. Fukuda. 1992. Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials. J. Biol. Chem. 267:5700-5711.